Literature DB >> 18497750

Integrins in angiogenesis and lymphangiogenesis.

Christie J Avraamides1, Barbara Garmy-Susini, Judith A Varner.   

Abstract

Blood vessels promote tumour growth, and both blood and lymphatic vessels facilitate tumour metastasis by serving as conduits for the transport of tumour cells to new sites. Angiogenesis and lymphangiogenesis are regulated by integrins, which are members of a family of cell surface receptors whose ligands are extracellular matrix proteins and immunoglobulin superfamily molecules. Select integrins promote endothelial cell migration and survival during angiogenesis and lymphangiogenesis, whereas other integrins promote pro-angiogenic macrophage trafficking to tumours. Several integrin-targeted therapeutic agents are currently in clinical trials for cancer therapy. Here, we review the evidence implicating integrins as a family of fundamental regulators of angiogenesis and lymphangiogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18497750      PMCID: PMC2577722          DOI: 10.1038/nrc2353

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  145 in total

Review 1.  Angiogenesis in life, disease and medicine.

Authors:  Peter Carmeliet
Journal:  Nature       Date:  2005-12-15       Impact factor: 49.962

Review 2.  Angiogenesis as a therapeutic target.

Authors:  Napoleone Ferrara; Robert S Kerbel
Journal:  Nature       Date:  2005-12-15       Impact factor: 49.962

Review 3.  A review: Integrin alphavbeta3-targeted molecular imaging and therapy in angiogenesis.

Authors:  Esther H Lim; Narasimhan Danthi; Mark Bednarski; King C P Li
Journal:  Nanomedicine       Date:  2005-06       Impact factor: 5.307

4.  Normal development, wound healing, and adenovirus susceptibility in beta5-deficient mice.

Authors:  X Huang; M Griffiths; J Wu; R V Farese; D Sheppard
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

5.  Cooperation between VEGF and beta3 integrin during cardiac vascular development.

Authors:  Sara M Weis; Jeffrey N Lindquist; Leo A Barnes; Kimberly M Lutu-Fuga; Jianhua Cui; Malcolm R Wood; David A Cheresh
Journal:  Blood       Date:  2006-10-24       Impact factor: 22.113

6.  Phase I trial of a monoclonal antibody specific for alphavbeta3 integrin (MEDI-522) in patients with advanced malignancies, including an assessment of effect on tumor perfusion.

Authors:  Douglas G McNeel; Jens Eickhoff; Fred T Lee; David M King; Dona Alberti; James P Thomas; Andreas Friedl; Jill Kolesar; Rebecca Marnocha; Jennifer Volkman; Jianliang Zhang; Luz Hammershaimb; James A Zwiebel; George Wilding
Journal:  Clin Cancer Res       Date:  2005-11-01       Impact factor: 12.531

7.  Drug evaluation: Volociximab, an angiogenesis-inhibiting chimeric monoclonal antibody.

Authors:  Scott K Kuwada
Journal:  Curr Opin Mol Ther       Date:  2007-02

8.  Prox1 induces lymphatic endothelial differentiation via integrin alpha9 and other signaling cascades.

Authors:  Koichi Mishima; Tetsuro Watabe; Akira Saito; Yasuhiro Yoshimatsu; Natsuko Imaizumi; Shinji Masui; Masanori Hirashima; Tohru Morisada; Yuichi Oike; Makoto Araie; Hitoshi Niwa; Hajime Kubo; Toshio Suda; Kohei Miyazono
Journal:  Mol Biol Cell       Date:  2007-02-07       Impact factor: 4.138

9.  alpha2beta1 integrin expression in the tumor microenvironment enhances tumor angiogenesis in a tumor cell-specific manner.

Authors:  Zhonghua Zhang; Norma E Ramirez; Thomas E Yankeelov; Zhengzhi Li; Laura E Ford; Ying Qi; Ambra Pozzi; Mary M Zutter
Journal:  Blood       Date:  2007-11-27       Impact factor: 22.113

10.  Beta1 integrin expression on endothelial cells is required for angiogenesis but not for vasculogenesis.

Authors:  Harikrishna Tanjore; Elisabeth M Zeisberg; Behzad Gerami-Naini; Raghu Kalluri
Journal:  Dev Dyn       Date:  2008-01       Impact factor: 3.780

View more
  382 in total

1.  Rap1 promotes VEGFR2 activation and angiogenesis by a mechanism involving integrin αvβ₃.

Authors:  Sribalaji Lakshmikanthan; Magdalena Sobczak; Changzoon Chun; Angela Henschel; Jillian Dargatz; Ramani Ramchandran; Magdalena Chrzanowska-Wodnicka
Journal:  Blood       Date:  2011-06-02       Impact factor: 22.113

2.  Endothelial laminins underlie the tip cell microenvironment.

Authors:  Jan Kitajewski
Journal:  EMBO Rep       Date:  2011-10-28       Impact factor: 8.807

Review 3.  Tips, stalks, tubes: notch-mediated cell fate determination and mechanisms of tubulogenesis during angiogenesis.

Authors:  Jennifer J Tung; Ian W Tattersall; Jan Kitajewski
Journal:  Cold Spring Harb Perspect Med       Date:  2012-02       Impact factor: 6.915

4.  A PKA-Csk-pp60Src signaling pathway regulates the switch between endothelial cell invasion and cell-cell adhesion during vascular sprouting.

Authors:  Hui Jin; Barbara Garmy-Susini; Christie J Avraamides; Konstantin Stoletov; Richard L Klemke; Judith A Varner
Journal:  Blood       Date:  2010-09-08       Impact factor: 22.113

Review 5.  Cell-matrix interactions in mammary gland development and breast cancer.

Authors:  John Muschler; Charles H Streuli
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-08-11       Impact factor: 10.005

6.  Homeostatic and tissue reparation defaults in mice carrying selective genetic invalidation of CXCL12/proteoglycan interactions.

Authors:  Patricia Rueda; Adèle Richart; Alice Récalde; Pamela Gasse; José Vilar; Coralie Guérin; Hugues Lortat-Jacob; Paulo Vieira; Franoise Baleux; Fabrice Chretien; Fernando Arenzana-Seisdedos; Jean-Sébastien Silvestre
Journal:  Circulation       Date:  2012-10-03       Impact factor: 29.690

7.  Retinal vascular repair and neovascularization are not dependent on CX3CR1 signaling in a model of ischemic retinopathy.

Authors:  Lian Zhao; Wenxin Ma; Robert N Fariss; Wai T Wong
Journal:  Exp Eye Res       Date:  2009-01-07       Impact factor: 3.467

8.  Optogenetic interrogation of integrin αVβ3 function in endothelial cells.

Authors:  Zhongji Liao; Ana Kasirer-Friede; Sanford J Shattil
Journal:  J Cell Sci       Date:  2017-09-01       Impact factor: 5.285

9.  Abnormal lymphangiogenesis in idiopathic pulmonary fibrosis with insights into cellular and molecular mechanisms.

Authors:  Souheil El-Chemaly; Daniela Malide; Enrique Zudaire; Yoshihiko Ikeda; Benjamin A Weinberg; Gustavo Pacheco-Rodriguez; Ivan O Rosas; Marta Aparicio; Ping Ren; Sandra D MacDonald; Hai-Ping Wu; Steven D Nathan; Frank Cuttitta; J Philip McCoy; Bernadette R Gochuico; Joel Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

10.  Dynamic Regulation of Integrin α6β4 During Angiogenesis: Potential Implications for Pathogenic Wound Healing.

Authors:  Diana Desai; Purva Singh; Livingston Van De Water; Susan E Laflamme
Journal:  Adv Wound Care (New Rochelle)       Date:  2013-10       Impact factor: 4.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.